Does Consuming Modified Plant Seed Oil Containing Fish Oil Fatty Acids Act in the Same Way as Consuming Fish Oil?
Can Oils Derived From Genetically-modified Plants Replace Fish Oil as a Source of Long Chain n-3 Polyunsaturated Fatty Acids in the Human Diet
1 other identifier
interventional
31
1 country
1
Brief Summary
Fish oil and oily fish contain omega 3 long chain polyunsaturated fatty acids known to be beneficial to health. Many people consume little, despite UK government recommendations to eat at least one portion of oily fish per week. Furthermore, despite modest consumption, fish stocks are declining due to over fishing. Therefore, there is a need for an alternative, sustainable and cost efficiently produced dietary source. A seed oil source of these fish oil-type fatty acids has been achieved by adding genes from other plant sources to the oil seed plant Camelina sativa. Camelina sativa, related to mustard and cabbage, has provided seed oil for human consumption for thousands of years. It was the most important oil seed plant in Europe until the 1900's. This research is being done to see if consuming fish oil-type fatty acids in Camelina seed oil allows the body to take up and use the fish oil fatty acids in the same way as it does from fish oil.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable healthy
Started Jun 2017
Longer than P75 for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 9, 2017
CompletedFirst Submitted
Initial submission to the registry
March 7, 2018
CompletedFirst Posted
Study publicly available on registry
March 26, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 4, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
November 4, 2019
CompletedJune 15, 2022
June 1, 2022
2.4 years
March 7, 2018
June 14, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Uptake of omega 3 polyunsaturated fatty acids after short term consumption of fish oil or Camelina seed oil.
The magnitude of the increase in omega 3 polyunsaturated fatty acids in plasma lipids and blood cells following consumption of modified Camelina seed oil for short (postprandial) period compared with fish oil.
Short term consumption - single dose followed over 8 hours
Uptake of omega 3 polyunsaturated fatty acids after longer term consumption of fish oil or Camelina seed oil.
The magnitude of the increase in omega 3 polyunsaturated fatty acids in plasma lipids and blood cells following consumption of modified Camelina seed oil for 8 weeks compared with fish oil.
Longer term consumption daily for 8 weeks. Follow up at 8 weeks.
Secondary Outcomes (2)
Effect of omega 3 polyunsaturated fatty acid consumption on postprandial inflammatory markers after consumption of fish oil or Camelina seed oil.
Short term consumption - single dose followed over 8 hours
Effect of omega 3 polyunsaturated fatty acid consumption for 8 weeks on in vitro immune responses after consumption of fish oil or Camelina seed oil.
Longer term consumption daily for 8 weeks. Follow up at 8 weeks.
Study Arms (2)
Fish oil
ACTIVE COMPARATORFish oil providing 450 mg of eicosapentaenoic acid plus docosahexaenoic acid per dose
Camelina seed oil
EXPERIMENTALCamelina seed oil providing 450 mg of eicosapentaenoic acid plus docosahexaenoic acid per dose
Interventions
camelina seed oil consumed within a single high fat test meal
camelina seed oil consumed daily for 8 weeks
Eligibility Criteria
You may qualify if:
- Male or female
- to 30 years or 50 to 65 years
- Body mass index 18.5-30.0 kg/m2
- Health screening results that are within normal clinical ranges
- Not consuming fish oil or other oil supplements
- Not eating more than one oily fish meal per week
- Willing to adhere to the study protocol
- Being able to provide written informed consent
You may not qualify if:
- Aged \< 18 years; 31-49 years or \> 65 years
- Body mass index \< 18.5 or \> 30 kg/m2
- Current smoker
- Fasting blood cholesterol or glucose concentrations outside the normal concentration range
- Diagnosed chronic illness (for example diagnosed cardiovascular disease, diabetes, cancer)
- Use of prescribed medicine to control inflammation
- Use of prescribed medication to control blood lipids (e.g. statins, fibrates (fenofibrate), Omacor)
- Use of prescribed medication to control blood pressure (ACE inhibitors, angiotensin 2 receptor blockers, calcium channel blockers, α-inhibitors, thiazide diuretics)
- Use of fish oil or other oil supplements
- Chronic gastrointestinal problems (e.g. IBD, coeliac disease, cancer)
- Pregnant or planning to become pregnant within the study period
- Participation in another clinical trial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculty of Medicine, University of Southampton
Southampton, Hants, SO16 6YD, United Kingdom
Related Publications (4)
West AL, Michaelson LV, Miles EA, Haslam RP, Lillycrop KA, Georgescu R, Han L, Sayanova O, Napier JA, Calder PC, Burdge GC. Differential postprandial incorporation of 20:5n-3 and 22:6n-3 into individual plasma triacylglycerol and phosphatidylcholine molecular species in humans. Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Aug;1865(8):158710. doi: 10.1016/j.bbalip.2020.158710. Epub 2020 Apr 11.
PMID: 32289503RESULTWest AL, Miles EA, Lillycrop KA, Han L, Napier JA, Calder PC, Burdge GC. Dietary supplementation with seed oil from transgenic Camelina sativa induces similar increments in plasma and erythrocyte DHA and EPA to fish oil in healthy humans. Br J Nutr. 2020 Nov 14;124(9):922-930. doi: 10.1017/S0007114520002044. Epub 2020 Jun 9.
PMID: 32513312RESULTWest AL, Michaelson LV, Miles EA, Haslam RP, Lillycrop KA, Georgescu R, Han L, Napier JA, Calder PC, Burdge GC. Lipidomic Analysis of Plasma from Healthy Men and Women Shows Phospholipid Class and Molecular Species Differences between Sexes. Lipids. 2021 Mar;56(2):229-242. doi: 10.1002/lipd.12293. Epub 2020 Dec 7.
PMID: 33284478RESULTWest AL, Miles EA, Lillycrop KA, Napier JA, Calder PC, Burdge GC. Genetically modified plants are an alternative to oily fish for providing n-3 polyunsaturated fatty acids in the human diet: A summary of the findings of a Biotechnology and Biological Sciences Research Council funded project. Nutr Bull. 2021 Mar;46(1):60-68. doi: 10.1111/nbu.12478. Epub 2020 Dec 23.
PMID: 33776584RESULT
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Graham C Burdge, PhD
University of Southampton
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 7, 2018
First Posted
March 26, 2018
Study Start
June 9, 2017
Primary Completion
November 4, 2019
Study Completion
November 4, 2019
Last Updated
June 15, 2022
Record last verified: 2022-06